MaxCyte, Inc. Common Stock (MXCT) is a publicly traded Healthcare sector company. As of September 11, 2026, MXCT trades at $1.16 with a market cap of $122.82M and a P/E ratio of -2.82. MXCT moved -2.52% today. Year to date, MXCT is -23.23%; over the trailing twelve months it is -16.20%. Its 52-week range spans $0.64 to $5.20. Analyst consensus is strong buy with an average price target of $4.00. Rallies surfaces MXCT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks MXCT insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $1.16 |
| Market Cap | $122.82M |
| P/E Ratio | -2.82 |
| EPS | $-0.42 |
| Dividend Yield | 0.00% |
| 52-Week High | $5.20 |
| 52-Week Low | $0.64 |
| Volume | 305.86K |
| Avg Volume | 0 |
| Revenue (TTM) | $33.03M |
| Net Income | $-44.63M |
| Gross Margin | 81.16% |
4 analysts cover MXCT: 0 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $4.00.